Organization · Venture Capital
NEXTBLUE
NEXTBLUE is a venture capital firm based in Tokyo, Japan, focused on empowering female founders in the health and wellness sector. The firm invests in early-stage startups, particularly those from Japan, Europe, and the United States.
Overview
What NEXTBLUE does
What NEXTBLUE is
NEXTBLUE is a venture capital firm based in Tokyo, Japan, focused on empowering female founders in the health and wellness sector. The firm invests in early-stage startups, particularly those from Japan, Europe, and the United States.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- March 7, 2026
Official channels
Find NEXTBLUE elsewhere
Open the official website or a supported primary organization account.
Capability profile
NEXTBLUE as a funder
Investment thesis
NEXTBLUE is dedicated to empowering female founders and investing in women's wellbeing through innovative startups, particularly in femtech and adjacent sectors. The organization bridges the gap between European and US startups and the Japanese market.
Focus narrative
NEXTBLUE invests in startups at the pre-seed to early stages, with a particular emphasis on those originating from Europe and the United States, as well as exceptional startups within Japan. The organization offers a range of services, including fundraising support, partnership development, and marketing assistance, specifically tailored for startups entering the Japanese market.
Value beyond capital
NEXTBLUE adds value to its portfolio companies by providing access to the Japanese market, facilitating partnerships with corporate investors, and offering support in business development, marketing, and fundraising. The organization leverages its network to help startups navigate the complexities of entering and succeeding in the Japanese market.
Terms and economics
- Typical check
- $100,000–$1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- EuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 26
- Recorded notable exits
- INFORICH
Portfolio context
NEXTBLUE has invested in a variety of notable companies, including Anise Health, a mental health platform tailored for Asian Americans; Kencko, a nutrition-focused startup; and INFORICH, which was listed on the Tokyo Stock Exchange Growth Market in 2022. Other portfolio companies include Josan-She’s, fufu, AOTEN, SPACER, and Trellis Health, among others.
Common questions
What to know about NEXTBLUE
Upseed classifies NEXTBLUE under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.